Nanoparticulate Pd-Sn Compounds Supported on Metal Oxides: Synthesis, Material and Catalytic Properties

The manufacture of chemicals requires innovation at the catalyst frontier so that processes can be developed with higher energy efficiency and increased facility of separation and recovery of products. Catalysts with high selectivity and activity control the overall efficiency of a process by avoiding unwanted side-reactions and increasing the conversion per unit time. Although processes catalysed by homogeneous catalysts have the advantage of offering better control and understanding of the reaction mechanism, their frequent dependence on expensive metals which are difficult to recover, often precludes their employment in large-scale applications. Heterogeneously catalysed reactions on the other hand, are not associated with problems regarding recycling and reuse of catalyst, contamination of products or intermediates. This work reports the synthesis, characterization and testing of Pd-Sn nanoalloy catalyst in the selective hydrogenation of 2-methyl-3-butyn-2-ol. Our results show that the Pd-Sn nanoalloy, of composition Pd2.8Sn, supported on ZnO (Pd2.8Sn/ZnO), offers very high activity and selectivity in the semi-hydrogenation of 2-methyl-3-butyn-2-ol to 2-methyl-3-buten-2-ol in the liquid phase. Under identical reaction conditions, Pd2.8Sn/ZnO shows activity, both turnover frequency and activity normalized by Pd content, significantly higher than Pd/CaCO3 (the Lindlar catalyst), with TOF of 137.6 s−1 compared to 79.2 s−1 for Pd/CaCO3 with approximately equal selectivity. The preparation of Pd2.8Sn/ZnO is achieved using a one-pot polyol procedure with the addition of a capping agent (polyvinylpyrrolidone) to control the particle size distribution. TEM shows nanoparticles evenly dispersed on the support, with a size distribution of 4.06 ± 0.75 nm. Single phase Pd2.8Sn was also prepared without the ZnO support, via the polyol method. Powder X-Ray diffraction data from the unsupported nanoalloy shows that the unit cell of Pd2.8Sn is face centred cubic with the Pd and Sn atoms occupying randomly the same crystallographic position. The chemical formula was calculated from a combination of ICP and PXRD analyses

Salivary and gut microbiomes play a significant role in in vitro oral bioaccessibility, biotransformation, and intestinal absorption of arsenic from food

The release of a toxicant from a food matrix during the gastrointestinal digestion is a crucial determinant of the toxicant's oral bioavailability. We present a modified setup of the human simulator of the gut microbial ecosystem (SHIME), with four sequential gastrointestinal reactors (oral, stomach, small intestine, and colon), including the salivary and colonic microbiomes. Naturally arsenic-containing rice, mussels, and nori seaweed were digested in the presence of microorganisms and in vitro oral bioaccessibility, bioavailability, and metabolism of arsenic species were evaluated following analysis by using HPLC/mass spectrometry. When food matrices were digested with salivary bacteria, the soluble arsenic in the gastric digestion stage increased for mussel and nori samples, but no coincidence impact was found in the small intestinal and colonic digestion stages. However, the simulated small intestinal absorption of arsenic was increased in all food matrices (1.2-2.7 fold higher) following digestion with salivary microorganisms. No significant transformation of the arsenic species occurred except for the arsenosugars present in mussels and nori. In those samples, conversions between the oxo arsenosugars were observed in the small intestinal digestion stage whereupon the thioxo analogs became major metabolites. These results expand our knowledge on the likely metabolism and oral bioavailabiltiy of arsenic during human digestion, and provide valuable information for future risk assessments of dietary arsenic

Developmental nmda receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model

Protein palmitoylation and depalmitoylation alter protein function. This post-translational modification is critical for synaptic transmission and plasticity. Mutation of the depalmitoylating enzyme palmitoyl-protein thioesterase 1 (PPT1) causes infantile neuronal ceroid lipofuscinosis (CLN1), a pediatric neurodegenerative disease. However, the role of protein depalmitoylation in synaptic maturation is unknown. Therefore, we studied synapse development in Ppt1-/- mouse visual cortex. We demonstrate that the developmental N-methyl-D-aspartate receptor (NMDAR) subunit switch from GluN2B to GluN2A is stagnated in Ppt1-/- mice. Correspondingly, Ppt1-/- neurons exhibit immature evoked NMDAR currents and dendritic spine morphology in vivo. Further, dissociated Ppt1-/- cultured neurons show extrasynaptic, diffuse calcium influxes and enhanced vulnerability to NMDA-induced excitotoxicity, reflecting the predominance of GluN2B-containing receptors. Remarkably, Ppt1-/- neurons demonstrate hyperpalmitoylation of GluN2B as well as Fyn kinase, which regulates surface retention of GluN2B. Thus, PPT1 plays a critical role in postsynapse maturation by facilitating the GluN2 subunit switch and proteostasis of palmitoylated proteins

Stabilization of Pd3−xIn1+x polymorphs with Pd-like crystal structure and their superior performance as catalysts for semi-hydrogenation of alkynes

Selective hydrogenation (semi-hydrogenation) reactions of alkynes rely on Pd-based catalysts to provide the correct pathway to favour formation of double bonds and avoid full hydrogenation to single bonds. Here, we present the preparation and characterisation of "Pd3In"/TiO2 nanocatalysts, which show improved activity and selectivity compared to pure Pd catalysts, towards the liquid phase semi-hydrogenation of 2-methyl-3-butyn-2-ol (MBY) to 2-methyl-3-buten-2-ol (MBE), a fundamental step in the preparation of pharmaceuticals, and other industrially produced substances, as well as a model reaction for the semi-hydrogenation of alkynes. For both the supported and unsupported "Pd3In" alloys (later redefined as Pd3-xIn1+x), we stabilised two new cubic polymorphs with a Pd-like structure, instead of the tetragonal structure as reported so far in the literature. The stabilisation of these new polymorphs was made possible by using a solution-based synthesis and, thanks to the use of different solvents, the reaction was 2 carried out at different temperatures and the Pd/In ratio could be tuned. The same synthetic approach was adapted to prepare two "Pd3In"/TiO2 catalysts by adding the TiO2 support to the reaction mixture, in a practical one-step, one-pot reaction. HREM and X-Ray maps show that the cubic crystal structure of "Pd3In" is maintained when prepared in the presence of the support, however, the support seems to influence the Pd/In ratio

Pd₃Sn nanoparticles on TiO₂ and ZnO supports as catalysts for semi-hydrogenation : synthesis and catalytic performance

The two catalysts Pd₃Sn/TiO₂and Pd3Sn/ZnO were prepared via a one-pot procedure based on the “polyol method” with the addition of a capping agent (polyvinylpyrrolidone) to control the particle size distribution. The same procedure was used to prepare Pd/TiO2 and Pd/ZnO for comparison. All four catalysts showed high activity and selectivity for the selective hydrogenation of 2-methyl-3-butyn-2-ol (MBY) to 2-methyl-3-buten-2-ol (MBE) in the liquid phase under identical conditions. However, Pd₃Sn/TiO₂and Pd₃Sn/ZnO show selectivities to alkene significantly higher than that of the Pd catalysts. Specifically, the selectivity increases from 96.4% to 97.4% on TiO₂support, and 96.2% to 97.6% on ZnO support, at 90% conversion. Transition electron microscopy shows nanoparticles evenly dispersed on the support, with mean particle sizes as low as 4.1 (±0.8) nm when Sn is incorporated into the catalyst. Unsupported Pd3Sn was prepared using the same method and characterised by powder X-Ray diffraction followed by the Rietveld refinement. Pd3Sn was found to be single-phase and isostructural to Pd metal with a face centred cubic unit cell

A Population-Based Case–Control Study of Urinary Arsenic Species and Squamous Cell Carcinoma in New Hampshire, USA

Background: Chronic high arsenic exposure is associated with squamous cell carcinoma (SCC) of the skin, and inorganic arsenic (iAs) metabolites may play an important role in this association. However, little is known about the carcinogenicity of arsenic at levels commonly observed in the United States. Objective: We estimated associations between total urinary arsenic and arsenic species and SCC in a U.S. population. Methods: We conducted a population-based case–control SCC study (470 cases, 447 controls) in a U.S. region with moderate arsenic exposure through private well water and diet. We measured urinary iAs, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), and summed these arsenic species (ΣAs). Because seafood contains arsenolipids and arsenosugars that metabolize into DMA through alternate pathways, participants who reported seafood consumption within 2 days before urine collection were excluded from the analyses. Results: In adjusted logistic regression analyses (323 cases, 319 controls), the SCC odds ratio (OR) was 1.37 for each ln-transformed microgram per liter increase in ln-transformed ΣAs concentration [ln(ΣAs)] (95% CI: 1.04, 1.80). Urinary ln(MMA) and ln(DMA) also were positively associated with SCC (OR = 1.34; 95% CI: 1.04, 1.71 and OR = 1.34; 95% CI: 1.03, 1.74, respectively). A similar trend was observed for ln(iAs) (OR = 1.20; 95% CI: 0.97, 1.49). Percent iAs, MMA, and DMA were not associated with SCC. Conclusions: These results suggest that arsenic exposure at levels common in the United States relates to SCC and that arsenic metabolism ability does not modify the association

Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%). Study objectives are to describe clinical manifestations and case management for 26 hospitalised laboratory-confirmed EHF patients. Clinical findings are congruous with previously reported EHF infections. The most frequently experienced symptoms were non-bloody diarrhoea (81%), severe headache (81%), and asthenia (77%). Seven patients reported or were observed with haemorrhagic symptoms, six of whom died. Ebola care remains difficult due to the resource-poor setting of outbreaks and the infection-control procedures required. However, quality data collection is essential to evaluate case definitions and therapeutic interventions, and needs improvement in future epidemics. Organizations usually involved in EHF case management have a particular responsibility in this respect

Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review

Background: The 2013-15 Ebola outbreak was unprecedented due to sustainedtransmission within urban environments and thousands of survivors. In 2014 the World Health Organization stated that there was insufficient evidence to give definitive guidance about which body fluids are infectious and when they pose a risk to humans. We report a rapid systematic review of published evidence on the presence of filoviruses in body fluids of infected people and survivors. Methods: Scientific articles were screened for information about filovirus in human body fluids. The aim was to find primary data that suggested high likelihood of actively infectious filovirus in human body fluids (viral RNA). Eligible infections were from Marburg virus (MARV or RAVV) and Zaire, Sudan, Taï Forest and Bundibugyo species of Ebola. [1] Cause of infection had to be laboratory confirmed (in practice either tissue culture or RT-PCR tests), or evidenced by compatible clinical history with subsequent positivity for filovirus antibodies or inflammatory factors. Data were extracted and summarized narratively. Results: 6831 unique articles were found, and after screening, 33 studies were eligible. For most body fluid types there were insufficient patients to draw strong conclusions, and prevalence of positivity was highly variable. Body fluids taken >16 days after onset were usually negative. In the six studies that used both assay methods RT-PCR tests for filovirus RNA gave positive results about 4 times more often than tissue culture. Conclusions: Filovirus was reported in most types of body fluid, but not in every sample from every otherwise confirmed patient. Apart from semen, most non-blood, RT-PCR positive samples are likely to be culture negative and so possibly of low infectious risk. Nevertheless, it is not apparent how relatively infectious many body fluids are during or after illness, even when culture-positive, not least because most test results come from more severe cases. Contact with blood and blood-stained body fluids remains the major risk for disease transmission because of the known high viral loads in blood